COVID-19: Important Post-Public Health Emergency Info | $0 Out-of-Pocket Testing Available
PATIENTS: Learn about our new bill-pay platform
Tuesday, April 18, 2023 | Category: Media Coverage
PHOENIX (April 18, 2023) -- Listen in as Check for a Lump interviews Dr. Xia Li, Sonora Quest Laboratories Scientific Medical Director, and she shares overview information on biomarker testing, its benefits for patients and health care providers, and how HB 2144, which took effect January 1, 2023, helps expand access to this individualized testing.
HB 2144 was signed by former governor Doug Ducey to provide patients with health insurance coverage for biomarker testing when there is a clinical need for it. Biomarker testing is a measurable indicator, such as a genetic mutation or protein level, that can help providers determine whether a biomarker is present and at what level. Hear Dr. Li explain the four types of biomarker testing and how it can help guide providers to maximize treatment effectiveness, minimize side effect, and promote better outcomes for patients.
This podcast is brought to you by Check for a Lump and is approximately 20 minutes.